MDM2 and melanoma: Moreover, genetic alterations targetable in other cancers were identified in KIT, PIK3CA, ATM, BRCA1, ERBB2, PDGFRA, CDK4, and MDM2, some of which were reported to respond to treatments also in melanoma cases in individual case reports [44, 45].